Pathogenesis of the hepatorenal syndrome.
This review examines current understanding about the patient with moderately advanced cirrhosis of the liver and his or her transition to hepatorenal syndrome (HRS). Special emphasis is given to three areas of ongoing research. Atrial natriuretic factor's role in the pathogenesis of salt and water retention is examined, as well as its role in determining volume status in these patients. The current literature regarding prostaglandins (PGs) is reviewed, with emphasis on how vasodilatory PGs appear first to help maintain homeostasis in advanced cirrhosis and how vasoconstrictor thromboxane may then be involved in the transition to HRS. Finally, new findings regarding the liver hormone glomerulopressin are examined, and how deficient release of this may lead to the decrease in glomerular filtration rate seen in HRS.
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology; D004537:Eicosanoic Acids / Q000378:metabolism; D005965:Glucuronates / Q000502:physiology; D006530:Hepatorenal Syndrome / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology; D006728:Hormones / Q000502:physiology; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology*; D008103:Liver Cirrhosis / Q000150:complications*
D004537:Eicosanoic Acids; D005965:Glucuronates; D006728:Hormones; C014007:glomerulopressin; D009320:Atrial Natriuretic Factor